Literature DB >> 29490250

The Chemical Potential of Plasma Membrane Cholesterol: Implications for Cell Biology.

Artem G Ayuyan1, Fredric S Cohen2.   

Abstract

Cholesterol is abundant in plasma membranes and exhibits a variety of interactions throughout the membrane. Chemical potential accounts for thermodynamic consequences of molecular interactions, and quantifies the effective concentration (i.e., activity) of any substance participating in a process. We have developed, to our knowledge, the first method to measure cholesterol chemical potential in plasma membranes. This was accomplished by complexing methyl-β-cyclodextrin with cholesterol in an aqueous solution and equilibrating it with an organic solvent containing dissolved cholesterol. The chemical potential of cholesterol was thereby equalized in the two phases. Because cholesterol is dilute in the organic phase, here activity and concentration were equivalent. This equivalence allowed the amount of cholesterol bound to methyl-β-cyclodextrin to be converted to cholesterol chemical potential. Our method was used to determine the chemical potential of cholesterol in erythrocytes and in plasma membranes of nucleated cells in culture. For erythrocytes, the chemical potential did not vary when the concentration was below a critical value. Above this value, the chemical potential progressively increased with concentration. We used standard cancer lines to characterize cholesterol chemical potential in plasma membranes of nucleated cells. This chemical potential was significantly greater for highly metastatic breast cancer cells than for nonmetastatic breast cancer cells. Chemical potential depended on density of the cancer cells. A method to alter and fix the cholesterol chemical potential to any value (i.e., a cholesterol chemical potential clamp) was also developed. Cholesterol content did not change when cells were clamped for 24-48 h. It was found that the level of activation of the transcription factor STAT3 increased with increasing cholesterol chemical potential. The cholesterol chemical potential may regulate signaling pathways.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29490250      PMCID: PMC5984996          DOI: 10.1016/j.bpj.2017.12.042

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  86 in total

1.  E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium.

Authors:  Elisabetta Carico; Marco Atlante; Enrico Giarnieri; Salvatore Raffa; Barbara Bucci; Maria Rosaria Giovagnoli; Aldo Vecchione
Journal:  Anticancer Res       Date:  2010-12       Impact factor: 2.480

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 3.  Functional rafts in cell membranes.

Authors:  K Simons; E Ikonen
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

4.  Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts.

Authors:  Y Lange; M H Swaisgood; B V Ramos; T L Steck
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

5.  Stoichiometry of cholesterol-sphingomyelin condensed complexes in monolayers.

Authors:  A Radhakrishnan; X M Li; R E Brown; H M McConnell
Journal:  Biochim Biophys Acta       Date:  2001-03-09

6.  Reduced alpha-catenin and E-cadherin expression in breast cancer.

Authors:  D L Rimm; J H Sinard; J S Morrow
Journal:  Lab Invest       Date:  1995-05       Impact factor: 5.662

7.  Variability of cholesterol accessibility in human red blood cells measured using a bacterial cholesterol-binding toxin.

Authors:  Rima S Chakrabarti; Sally A Ingham; Julia Kozlitina; Austin Gay; Jonathan C Cohen; Arun Radhakrishnan; Helen H Hobbs
Journal:  Elife       Date:  2017-02-08       Impact factor: 8.140

8.  Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.

Authors:  Marjan Berishaj; Sizhi Paul Gao; Simi Ahmed; Kenneth Leslie; Hikmat Al-Ahmadie; William L Gerald; William Bornmann; Jacqueline F Bromberg
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts.

Authors:  C J Watson; W R Miller
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

10.  Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma.

Authors:  N Tanaka; T Odajima; K Ogi; T Ikeda; M Satoh
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

View more
  5 in total

1.  The Membrane "Pull" That Balances Metabolism's "Push" in Lipid Homeostasis.

Authors:  Thomas R Shaw; Sarah L Veatch
Journal:  Biophys J       Date:  2020-08-05       Impact factor: 4.033

Review 2.  Critical Phenomena in Plasma Membrane Organization and Function.

Authors:  Thomas R Shaw; Subhadip Ghosh; Sarah L Veatch
Journal:  Annu Rev Phys Chem       Date:  2020-12-01       Impact factor: 12.703

3.  Criticality of plasma membrane lipids reflects activation state of macrophage cells.

Authors:  Eugenia Cammarota; Chiara Soriani; Raphaelle Taub; Fiona Morgan; Jiro Sakai; Sarah L Veatch; Clare E Bryant; Pietro Cicuta
Journal:  J R Soc Interface       Date:  2020-02-05       Impact factor: 4.118

4.  Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.

Authors:  Gourab Das; Troyee Das; Nilkanta Chowdhury; Durbadal Chatterjee; Angshuman Bagchi; Zhumur Ghosh
Journal:  Genomics       Date:  2020-11-13       Impact factor: 5.736

5.  Ion channels can be allosterically regulated by membrane domains near a de-mixing critical point.

Authors:  Ofer Kimchi; Sarah L Veatch; Benjamin B Machta
Journal:  J Gen Physiol       Date:  2018-11-19       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.